Booths: 212, 213

Roche Diagnostics
Booths: 210, 211


DAWN Anticoagulation software is a decision support package that supports the management of anticoagulation clinics across North America, UK and around the world. The software includes Induction, Maintenance, Bridging and DOACs to deliver a reliable, disease specific solution that increases patient safety, facilitates healthcare professional productivity and improves quality of care.
Booth: 103

Acelis Connected Health
Booth: 106

Aniara Diagnostica
Booth: 105

Anticoagulation Centers of Excellence
Booth: 101

BMS Pfizer
Pfizer and Bristol-Myers Squibb are partners in a worldwide collaboration. This global alliance combines both Bristol-Myers Squibb's and Pfizer’s long-standing strengths in drug development and commercialization.
Booth: 100

CoaguSense’s mission is to bring more accurate and affordable anticoagulation monitoring technology to both clinicians and patients. The Company’s NEW product is the Coag-Sense® PT/INR Monitoring System which incorporates a novel direct clot detection technology, emulating the WHO gold standard tilt-tube method while requiring only a very small blood sample.
Booth: 102

Booth: 204

National Blood Clot Alliance
The National Blood Clot Alliance (NBCA) is the leading patient advocacy organization in the United States focused on reducing death and disability from blood clots, regardless of cause. NBCA programs create public awareness about blood clots and educate patients and families about blood clot diagnosis, treatment and prevention.
Booth: 208

Booth: 209

NATF’s vision is to improve patient care, outcomes, and public health by utilizing a multi-disciplinary approach to advance thrombosis research and education. NATF supports thrombosis-related programs, innovative educational programs, public policy initiatives, regulatory issues, and advocacy. NATF also seeks to broaden training opportunities for physicians, scientists, and other health professionals.
Booth: 206

PERT Consortium
Booth: 205

PCDS Anticoagulation software uses established quality metrics and evidence-based guidelines that merge with patient data providing recommendations for treatment parameters. The application helps to reduce adverse risks and re-admissions. Integrates with EMRs to eliminate redundant data entry, accelerating aggregation of patient conditions and providing measurable outcomes.
Booth: 108


University of Southern Indiana
Booth: 207